Aqua Bio Technology ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	94.88	106.56	18.41	7.02	1.56	0.44
Other Revenue	6.63	0.62	0.33	0.14	0.42	0.37
Revenue	101.51	107.17	18.74	7.16	1.98	0.81
Revenue Growth (YoY)	293.26%	472.00%	161.63%	262.49%	143.11%	-37.26%
Cost of Revenue	101.02	104.54	8.34	4.69	0.95	0.98
Gross Profit	0.49	2.63	10.4	2.47	1.02	-0.17
Selling, General & Admin	99.09	113.77	36	21.52	17.79	15.82
Operating Expenses	109.13	125.51	39.68	23.18	18.88	15.94
Operating Income	-108.64	-122.88	-29.28	-20.71	-17.86	-16.1
Interest Expense	-23.62	-19.01	-4.49	-2.24	-1.46	-0
Interest & Investment Income	0.24	0.3	0.06	0	-	0
Currency Exchange Gain (Loss)	-0.01	-0.01	-0.31	-0.15	0.2	-0.06
Other Non Operating Income (Expenses)	-0.73	-0.73	-0.31	-	-	1.21
EBT Excluding Unusual Items	-132.76	-142.33	-34.34	-23.1	-19.11	-14.95
Gain (Loss) on Sale of Assets	-44.71	-44.71	-	-	-	-
Asset Writedown	-158.19	-163.7	-0.8	-	-	-
Other Unusual Items	8.52	5.57	14.3	4.34	-	-
Pretax Income	-274.28	-345.17	-20.85	-18.75	-19.11	-14.95
Income Tax Expense	-8.24	-7.81	0.18	-0.02	-	-0.25
Net Income	-144.7	-337.35	-21.02	-18.74	-19.11	-14.7
Net Income to Common	-144.7	-337.35	-21.02	-18.74	-19.11	-14.7
Shares Outstanding (Basic)	109	68	31	21	19	16
Shares Outstanding (Diluted)	109	68	31	21	19	16
Shares Change (YoY)	96.11%	122.82%	47.34%	7.88%	18.67%	25.77%
EPS (Basic)	-1.32	-4.96	-0.69	-0.91	-0.99	-0.91
EPS (Diluted)	-1.32	-4.96	-0.69	-0.92	-0.99	-0.91
Free Cash Flow	-17.62	-47.93	-19.34	-15.45	-20.97	-13.47
Free Cash Flow Per Share	-0.16	-0.70	-0.63	-0.74	-1.09	-0.83
Gross Margin	0.48%	2.45%	55.51%	34.52%	51.82%	-20.78%
Operating Margin	-107.02%	-114.66%	-156.29%	-289.21%	-903.89%	-1981.81%
Profit Margin	-142.55%	-314.77%	-112.21%	-261.62%	-967.45%	-1809.43%
Free Cash Flow Margin	-17.35%	-44.72%	-103.24%	-215.73%	-1061.42%	-1657.67%
EBITDA	-102.85	-116.33	-27.27	-19.47	-16.9	-15.99
EBITDA Margin	-101.32%	-108.55%	-145.57%	-271.94%	-	-
D&A For EBITDA	5.79	6.54	2.01	1.24	0.96	0.11
EBIT	-108.64	-122.88	-29.28	-20.71	-17.86	-16.1
EBIT Margin	-107.02%	-114.65%	-156.29%	-289.21%	-	-
Revenue as Reported	101.51	107.17	18.74	7.16	1.98	0.81

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.